Figures & data
Table 1. Baseline characteristics of patients at study entry.
Figure 1. Left ventricular Mass on MRI. Mean decrease in left ventricular mass compared to baseline was 0.54% (n = 10), 8.5% (n = 10), and 11.5% (n = 8) at 1, 2, and 3 years respectively.
![Figure 1. Left ventricular Mass on MRI. Mean decrease in left ventricular mass compared to baseline was 0.54% (n = 10), 8.5% (n = 10), and 11.5% (n = 8) at 1, 2, and 3 years respectively.](/cms/asset/b19141bc-a07e-4fa7-a025-a3f1c203c987/iamy_a_1685487_f0001_b.jpg)
Figure 2. Echocardiogram and MRI of a subject with hereditary ATTR cardiomyopathy: Top (Echocardiogram): IVS decreased from 1.8 cm (left) at baseline to 1.4 cm at 2.5 years (right). Bottom (MRI): LVM decreased from 331 grams at baseline (left) to 149 grams at 3 years (right).
![Figure 2. Echocardiogram and MRI of a subject with hereditary ATTR cardiomyopathy: Top (Echocardiogram): IVS decreased from 1.8 cm (left) at baseline to 1.4 cm at 2.5 years (right). Bottom (MRI): LVM decreased from 331 grams at baseline (left) to 149 grams at 3 years (right).](/cms/asset/ceb2c1f1-3ac5-4233-b4e6-99fda247be77/iamy_a_1685487_f0002_c.jpg)
Figure 3. Interventricular septal thickness on Echo compared to baseline (n = 20) was stable at one year (n = 20) and decreased by 0.14 cm (n = 16) at 2 years and 0.3 cm (n = 14) at 3 years (p = .019) in all patients (hereditary and wild-type) as shown by the center line. The decrease in wall thickness was similar in the wild-type patients (bottom line) and the hereditary patients (top line).
![Figure 3. Interventricular septal thickness on Echo compared to baseline (n = 20) was stable at one year (n = 20) and decreased by 0.14 cm (n = 16) at 2 years and 0.3 cm (n = 14) at 3 years (p = .019) in all patients (hereditary and wild-type) as shown by the center line. The decrease in wall thickness was similar in the wild-type patients (bottom line) and the hereditary patients (top line).](/cms/asset/76e5e475-a31c-4214-af07-58c48c4618c6/iamy_a_1685487_f0003_c.jpg)
Figure 4. Center line: 6MWT in patients tested at 1, 2, and 3 years. Mean 6MWT increased by 10.63 (n = 19), 22.2 (n = 14) and 16.5 (n = 12) meters compared to baseline at 1, 2, and 3 years respectively. Top line: 6-MWT in ATTRm patients. Mean 6-MWT increased by 29.3 (n = 8), 40.9 (n = 8) and 50.2 (n = 7) meters at 1, 2, and 3 years respectively. Bottom line: 6-MWT in ATTRwt patients. Mean 6MWT decreased by 3 (n = 11), 2.6 (n = 6), and 31.7 (n = 5) metres compared to baseline at 1, 2, and 3 years respectively.
![Figure 4. Center line: 6MWT in patients tested at 1, 2, and 3 years. Mean 6MWT increased by 10.63 (n = 19), 22.2 (n = 14) and 16.5 (n = 12) meters compared to baseline at 1, 2, and 3 years respectively. Top line: 6-MWT in ATTRm patients. Mean 6-MWT increased by 29.3 (n = 8), 40.9 (n = 8) and 50.2 (n = 7) meters at 1, 2, and 3 years respectively. Bottom line: 6-MWT in ATTRwt patients. Mean 6MWT decreased by 3 (n = 11), 2.6 (n = 6), and 31.7 (n = 5) metres compared to baseline at 1, 2, and 3 years respectively.](/cms/asset/9cf8ed0f-3ccf-4d97-a8f1-9ac685dd50b4/iamy_a_1685487_f0004_c.jpg)